|Articles|October 1, 2015
- Applied Clinical Trials-10-01-2015
- Volume 24
- Issue 10
Applied Clinical Trials Digital Edition - October/November 2015
Trial Design: Gene Transfer: Key Challenges Therapy Masking Assessment Safety Reporting: Death Waivers Fall Short Subject Engagement: Phase I Satisfaction Scores Also in this issue: Informed Consent Changes in Works Europe's Embrace of New Science Alzheimer's and Patient Safety
Advertisement
Articles in this issue
over 10 years ago
Top Investigator Lays out Strategy for Avoiding Conflictsover 10 years ago
Changes Ahead for Informed Consent, IRBs, Transparencyover 10 years ago
Europe: At Last, the Hunt is On for Trials That Fit Scienceover 10 years ago
Developing New Alzheimer’s Drugs With a Focus on Patient Safetyover 10 years ago
Inclusion/Exclusion Criteria Show Minimal Riseover 10 years ago
A New Look at the Arsenal of Tech Solutionsover 10 years ago
Human Gene Transfer Studies: What Clinicians Should Knowover 10 years ago
Death Waivers an Incomplete Picture of Drug Safetyover 10 years ago
Evaluating the Effects of Therapy Maskingover 10 years ago
Satisfaction of Healthy Subjects in Phase I TrialsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
2
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
3
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
4
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
5